Etorite-MR 10 Tablets

babies: not recommended for children. lactating mothers: information regarding its safety profile while breastfeeding is not available.
need to seek doctors’ advice. pregnancy: need to seek doctors’ advice before taking this medication.
driving: etodolac and thiocolchicoside tablets may cause dizziness and drowsiness. do not drive if these symptoms occur.
alcohol: avoid consuming alcohol while on this tablet as it can increase the risk of stomach bleeding. liver: these tablets should use with caution in patients with liver disease.
you may require dosage adjustment and regular monitoring of liver function. seek doctor advice before using this medication. kidney: etodolac and thiocolchicoside tablet is safe for use in kidney disease.
however, you may require regular monitoring of kidney function. seek doctor’s advice before using this medication .

Nausea Vomiting Heartburn Stomach pain/epigastric pain Loss of appetite Indigestion Sleepiness .

ETORITE MR is a non-steroidal anti-inflammatory drug (nsaid), which works by inhibiting a substance called prostaglandin responsible for pain & inflammation. thiocolchicoside works by relieving muscle stiffness or spasm in particular centers of the brain and spinal cord..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• take this medication with food to avoid stomach upset • do not use this medication for more days than is recommended by your doctor • alcohol consumption needs to be avoided while on this medication as it may increase the risk of stomach bleeding • inform your doctor if you are pregnant or breastfeeding • use this medication along with rest and physical therapy to get maximum pain relief.

contraindicated • etodolac + ketorolac: concurrent use may result in enhanced gastrointestinal adverse effects. major • etodolac + abciximab: concurrent use may result in an increased risk of bleeding. • etodolac + amiloride: concurrent use may result in reduced diuretic effectiveness, possible nephrotoxicity, hyperkalemia • etodolac + clopidogrel: concurrent use leads to increased risk of bleeding.